8 completed, 2 terminated. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Terminated 2 |
| Phase 2 | 2 | Completed 2 |
Follow Agensys, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 AGS-1C4D4, gemcitabine - Pancreatic Cancer, Carcinoma, Pancreatic Ductal | Phase 2 | Completed | Agensys, Inc. | 2 | 2012-08-07 | 2017-05-16 |
| A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology AGS-16C3F - Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology | Phase 1 | Completed | Agensys, Inc. | 34 | 2012-07-18 | 2024-11-01 |
| A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4 AGS-22M6E, ASG-22CE - Tumors, Medical Oncology | Phase 1 | Completed | Astellas Pharma Inc | 34 | 2011-07-11 | 2024-03-12 |
| A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer AGS-16M8F - Renal Cell Carcinoma, Pharmacokinetics of AGS-16M8F | Phase 1 | Completed | Astellas Pharma Inc | 26 | 2010-08-01 | 2012-12-12 |
| A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma ASG-5ME - Gastric Neoplasms, Pancreatic Neoplasms | Phase 1 | Completed | Seagen Inc. | 51 | 2010-07-01 | 2013-08-27 |
| A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer AGS-8M4, Pegylated liposomal doxorubicin (PLD), gemcitabine - Carcinoma, Ovarian Cancer | Phase 1 | Terminated | Astellas Pharma Inc | 4 | 2009-10-01 | 2013-02-27 |
| A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer AGS-1C4D4, Gemcitabine - Carcinoma, Pancreatic Ductal, Pancreatic Cancer | Phase 2 | Completed | Astellas Pharma Inc | 205 | 2009-04-01 | 2015-09-14 |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer AGS-16M18 - Carcinoma, Renal Cell, Kidney Neoplasms | Phase 1 | Terminated | Astellas Pharma Inc | 7 | 2008-10-01 | 2013-02-27 |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer AGS-8M4 - Carcinoma, Ovarian Cancer | Phase 1 | Completed | Astellas Pharma Inc | 18 | 2008-10-01 | 2013-02-27 |
| AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer AGS-1C4D4 - Prostate Cancer | Phase 1 | Completed | Astellas Pharma Inc | 13 | 2007-09-01 | 2014-05-02 |
Carcinoma (3) · Carcinoma, Renal Cell (3) · Pancreatic Neoplasms (3) · Carcinoma, Pancreatic Ductal (2) · Ovarian Diseases (2) · Ovarian Neoplasms (2) · Pancreatic Diseases (2) · Kidney Diseases (1) · Kidney Neoplasms (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1)
Gemcitabine (3) · MK-4721 (3) · AGS-16C3F (1) · ASG-5ME (1) · Carboplatin (1) · enfortumab vedotin (1) · liposomal doxorubicin (1)
United States (10) · Canada (4) · France (1) · Russia (1) · Spain (1)
Nancy Whiting, PharmD, BCOP (1)
2009 (1)